```html

Enteric Fever (Typhoid) – A Complete Patient Guide

Overview

Enteric fever, commonly known as typhoid fever, is a systemic bacterial infection caused primarily by Salmonella enterica serotype Typhi (S. Typhi). It spreads through ingestion of food or water contaminated with the feces of an infected person. In rare cases, Salmonella Paratyphi A, B, or C can cause a clinically similar illness called paratyphoid fever.

Who it affects: Typhoid is most common in children and young adults (5‑30 years) living in or traveling to regions with poor sanitation. However, anyone who consumes contaminated food or water can become infected.

Prevalence: According to the World Health Organization (WHO), there are an estimated 10–20 million new cases of typhoid worldwide each year, resulting in 100 000–150 000 deaths [1]. The burden is highest in South Asia (India, Bangladesh, Pakistan), sub‑Saharan Africa, and parts of Central America. In high‑income countries, cases are rare and usually linked to travel.

Symptoms

Symptoms typically appear 6‑30 days after exposure (average 10–14 days). The illness progresses through three phases: enteric fever, complication, and convalescence. Not all patients experience every symptom, and some may have a mild “carrier” state with no symptoms.

• Fever – Persistent high fever (38‑40 °C/101‑104 °F), often rising in a stepwise pattern.
• Headache – Dull, frontal headache that may worsen with fever.
• Weakness & Fatigue – Profound tiredness, sometimes lasting weeks after fever resolves.
• Abdominal Pain – Crampy, usually in the lower abdomen.
• Gastro‑intestinal disturbances:
  • Diarrhea (more common in children) or constipation (more common in adults).
  • Nausea and occasional vomiting.
• Rose‑colored spots – Small, flat, salmon‑pink maculopapular lesions on the trunk, seen in ~5 % of patients.
• Hepatosplenomegaly – Enlargement of liver and spleen detected on exam.
• Relative bradycardia (Faget sign) – Pulse rate lower than expected for the degree of fever.
• Elevated liver enzymes – Mild transaminitis on blood tests.
• Weight loss – Unintentional loss of 2–5 kg over weeks.
• Neurologic signs (rare) – Delirium, confusion, or seizures in severe disease.

Causes and Risk Factors

Pathogen

S. Typhi is a Gram‑negative, flagellated bacillus that exclusively infects humans. After ingestion, the bacteria invade the intestinal mucosa, multiply within macrophages, and disseminate via the bloodstream to reticuloendothelial organs (liver, spleen, bone marrow).

Transmission

• Contaminated water – Drinking untreated surface water, municipal water with filtration failures, or ice made from such water.
• Contaminated food – Raw fruits/vegetables washed with unsafe water, salads, street‑food items handled by infected carriers without proper hand hygiene.
• Fecal‑oral route – Direct contact with feces of an infected person, especially in settings lacking toilet facilities.

Risk Factors

• Travel to endemic regions (especially staying with local families, backpacking, or volunteering).
• Living in areas with inadequate sewage disposal and unsafe drinking water.
• Being a chronic carrier (≈2‑5 % of infected individuals continue to excrete S. Typhi >1 year, often after gallbladder colonisation).
• Age 5‑30 years (higher exposure due to social activities).
• Immunocompromised state (HIV, malignancy, chronic steroid use) – may lead to more severe disease.
• Use of antibiotics for unrelated infections can mask symptoms, delaying diagnosis.

Diagnosis

Early diagnosis is essential because untreated typhoid carries a mortality of 10‑30 % [2]. Diagnosis combines clinical suspicion with laboratory confirmation.

Laboratory Tests

1. Blood culture – Gold standard; positivity rate 40‑80 % if taken before antibiotics. Usually performed 2–3 days after fever onset.
2. Bone‑marrow culture – Highest yield (up to 90 %) but invasive; reserved for cases where blood cultures are negative but suspicion remains high.
3. Stool and urine cultures – Helpful after the first week or for identifying chronic carriers.
4. Serologic tests (e.g., Widal test) – Detects anti‑O and anti‑H antibodies. Generally discouraged because of poor sensitivity/specificity; may be used in resource‑limited settings with caution.
5. Rapid antigen detection kits (e.g., Typhidot, Tubex) – Provide quicker results but still have variable accuracy; best used as adjuncts.

Additional Studies

• Complete blood count – May show mild leukopenia with neutropenia.
• Liver function tests – Mild elevation of AST/ALT.
• Electrolytes – Assess dehydration.
• Imaging (ultrasound/CT) – Reserved for complications such as intestinal perforation or abscess.

Treatment Options

Effective therapy relies on antibiotics that target the bacterial strain’s susceptibility pattern. Resistance patterns vary regionally; local antibiograms should guide selection.

First‑Line Antibiotics (as of 2024)

• Ceftriaxone 2 g IV/IM daily for 10‑14 days – Preferred in areas with high fluoroquinolone resistance.
• Azithromycin 1 g PO once, then 500 mg daily for 5 days – Oral option, especially useful for mild‑moderate disease.

Alternative Agents

• Fluoroquinolones (e.g., ciprofloxacin 500 mg PO BID) – Still effective in regions with low resistance but should be confirmed with susceptibility testing.
• Carbapenems (imipenem, meropenem) – Reserved for multidrug‑resistant (MDR) or extensively drug‑resistant (XDR) strains.
• Chloramphenicol – Historically first line; now rarely used due to toxicity and resistance.

Management of Complications

• Intestinal perforation – Urgent surgical repair plus broad‑spectrum IV antibiotics.
• Severe hemorrhage – Endoscopic evaluation, blood transfusion, and possible embolization.
• Persistent carriage – Cholecystectomy combined with oral antibiotics (e.g., amoxicillin‑clavulanate) in selected cases.

Supportive Care

• Hydration – Oral rehydration salts (ORS) or IV fluids for severe dehydration.
• Antipyretics – Acetaminophen for fever; avoid NSAIDs if GI bleeding risk.
• Nutrition – High‑protein, low‑fiber diet during acute phase; gradual return to normal diet.

Living with Enteric Fever (Typhoid)

Even after successful treatment, patients may need guidance to recover fully and prevent relapse.

• Complete the full antibiotic course even if you feel better; stopping early can foster resistance.
• Monitor temperature twice daily for two weeks post‑therapy; report fever >38 °C lasting >48 h.
• Stay hydrated – Aim for ≥2 L of fluid daily; consider oral rehydration solutions if diarrhea persists.
• Gradual activity – Resume light activities after 3‑5 days; avoid heavy exertion for at least 2 weeks.
• Follow‑up labs – Repeat blood culture 1 week after therapy if symptoms linger; liver function tests may be checked if jaundice was present.
• Identify carrier status – If you continue to shed bacteria (positive stool culture after 1 month), discuss repeat testing and possible cholecystectomy with your physician.
• Vaccination – Get a typhoid vaccine (live oral Ty21a or injectable Vi capsular polysaccharide) before future travel.

Prevention

Prevention focuses on breaking the fecal‑oral transmission cycle.

1. Vaccination – Recommended for all travelers to endemic areas, infants ≥6 months in high‑risk regions, and laboratory personnel handling S. Typhi. Protection lasts 2‑5 years depending on the vaccine.
2. Safe drinking water – Use bottled, boiled (≥1 min), or filtered water; avoid ice cubes unless you are certain of water source.
3. Food hygiene –
   • Eat foods that are thoroughly cooked and served hot.
   • Peel fruits and vegetables yourself.
   • Avoid raw salads, unpasteurized dairy, and street‑food vendors with poor sanitation.
4. Hand hygiene – Wash hands with soap and water after using the toilet, before preparing food, and before eating. Alcohol‑based hand rubs are a useful adjunct when soap isn’t available.
5. Sanitation infrastructure – Support community initiatives for clean water supplies and proper sewage disposal.
6. Travel precautions – For high‑risk trips, carry a personal water purification method (e.g., chlorine dioxide tablets) and oral rehydration packets.

Complications

If untreated or inadequately treated, typhoid can lead to severe, life‑threatening complications:

• Intestinal hemorrhage – Usually from ulceration in the ileum; may present as melena or hematochezia.
• Intestinal perforation – Occurs in 1‑3 % of cases, typically in the third week; requires emergency surgery.
• Hepatic involvement – Typhoid hepatitis with jaundice; rarely progresses to fulminant liver failure.
• Encephalopathy – Confusion, seizures, or coma, especially in elderly or malnourished patients.
• Cardiovascular – Myocarditis, endocarditis (rare).
• Recurrent infection – Due to chronic carrier state or antibiotic resistance.
• Mortality – Up to 30 % in untreated cases; reduced to <1 % with appropriate antibiotics.

When to Seek Emergency Care

---

References:

1. World Health Organization. Typhoid Fever. WHO Fact Sheet, 2023. https://www.who.int/news-room/fact-sheets/detail/typhoid
2. Mayo Clinic. Typhoid fever. Updated 2024. https://www.mayoclinic.org
3. CDC. Typhoid Fever – Diagnosis. 2024. https://www.cdc.gov/typhoid/diagnosis.html
4. Cleveland Clinic. Typhoid Fever Treatment. 2024. https://my.clevelandclinic.org
5. Johns Hopkins Medicine. Antibiotic Resistance in Typhoid Fever. 2023. https://www.hopkinsmedicine.org

```